Brooks Laboratories Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.10 | 0.10 | 0.11 | 0.22 | 0.29 |
Long Term Debt-Equity Ratio | 0.01 | 0.01 | 0.02 | 0.08 | 0.13 |
Current Ratio | 1.05 | 0.94 | 1.02 | 0.88 | 0.88 |
Fixed Assets | 3.45 | 2.53 | 3.78 | 1.02 | 0.53 |
Inventory | 7.60 | 3.98 | 5.31 | 5.91 | 5.85 |
Debtors | 5.47 | 4.00 | 6.25 | 6.14 | 5.17 |
Interest Cover Ratio | 2.86 | -9.62 | 1.61 | -1.60 | -3.04 |
PBIDTM (%) | 5.25 | -10.26 | 3.33 | 2.47 | -5.05 |
PBITM (%) | 3.02 | -13.36 | 1.39 | -6.70 | -14.59 |
PBDTM (%) | 4.19 | -11.65 | 2.46 | -1.73 | -9.86 |
CPM (%) | 4.15 | -11.63 | 2.47 | -11.00 | -25.44 |
APATM (%) | 1.92 | -14.73 | 0.53 | -20.18 | -34.98 |
ROCE (%) | 2.72 | 0.00 | 1.23 | 0.00 | -7.66 |
RONW (%) | 1.90 | 0.00 | 0.52 | 0.00 | -23.95 |